Summary
- Combination of two immunotherapy drugs could treat microsatellite stable metastatic colorectal cancer
- Both drugs trigger the body’s immune system to attack cancer cells
- Tumours shrank or remained stable in 61% of patients after six months
- Hope for new treatment options for those diagnosed with bowel cancer
